Roche, through its Genentech subsidiary, is investing $95m in SR One-backed Constellation Pharmaceuticals as part of a partnership to develop a new breed of gene-based drugs.

The Medicines Company invests $8m in GeNO, which is researching nitric oxide treatments.

The biotechnology researcher, backed by a GlaxoSmithKline-linked venture capital firm, has set the range for its shares for its initial public offering at between $9 and $11.

The Korea Seoul Life Science Fund, which numbers conglomerate Hanwha among its backers, has invested $2.6m in biopharma company CrystalGenomics.

The VC firm, Access BridgeGap, will back three to five early-stage therapeutics companies per year.

The VC firm, Access BridgeGap, will back three to five early-stage therapeutics companies per year.

University of Leeds spin-out Tissue joined the Alternative Investment Market in June 2010 through the reverse takeover of listed Oxeco.

The Leonard and Madlyn Abramson Family Cancer Research Institute at the Abramson Cancer Center of the University of Pennsylvania has sued Craig Thompson (pictured) and healthcare companies Agios Pharmaceuticals and Celgene, in Federal Court, according to news provider Courthouse News.

The Leonard and Madlyn Abramson Family Cancer Research Institute at the Abramson Cancer Center of the University of Pennsylvania has sued Craig Thompson and healthcare companies Agios Pharmaceuticals and Celgene, in Federal Court, according to news provider Courthouse News.

Enobia has raised more than $145m from universities seed fund T2C2 (Technology, Transfer, Commercialisation, Capital) and venture capital firms.